Restricted accessLetterFirst published online 2013-12
Comments on Petrak et al.'s “Psychological Insulin Resistance in Type 2 Diabetes Patients Regarding Oral Antidiabetes Treatment,Subcutaneous Insulin Injections,or Inhaled Insulin”: Considerations for Language and Communication
PetrakF, HerpertzS, StriddeE, PfütznerA: Psychological insulin resistance in type 2 diabetes patients regarding oral antidiabetes treatment, subcutaneous insulin injections, or inhaled insulin. Diabetes Technol Ther, 2013; 15:702–710.
2.
InzucchiSE, BergenstalRM, BuseJB, DiamantM, FerranniniE, NauckM, PetersAL, TsapasA, WenderR, Matthews DR; American Diabetes Association (ADA); European Association for the Study of Diabetes (EASD): Management of hyperglycemia in type 2 diabetes: a patient-centered approach position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care, 2012; 35:1364–1379.
3.
SpeightJ, ConnJ, DunningT, SkinnerTC; Diabetes Australia: Diabetes Australia position statement. A new language for diabetes: improving communications with and about people with diabetes. Diabetes Res Clin Pract, 2012; 97:425–431.
4.
KhanH, LaskerSS, ChowdhuryTA: Prevalence and reasons for insulin refusal in Bangladeshi patients with poorly controlled type 2 diabetes in East London. Diabet Med, 2008; 25:1108–1111.
5.
GhermanA, VeresiuIA, SassuRA, SchnurJB, SchecknerBL, MontgomeryGH: Psychological insulin resistance: A critical review of the literature. Pract Diab Int, 2011; 28:125–128d.
